Wordt geladen...
Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation
Designer natriuretic peptides (NPs) represent an active area of drug development. In canine and human studies, the designer natriuretic peptide CD-NP demonstrated more desirable therapeutic potential than recombinant B-type NP (BNP), which is known as nesiritide and is approved for treatment of acut...
Bewaard in:
| Gepubliceerd in: | J Mol Cell Cardiol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4855506/ https://ncbi.nlm.nih.gov/pubmed/21459096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yjmcc.2011.03.013 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|